State DC
Clinical Trials in Washington D.C.
Recruiting clinical trials with at least one study location in Washington D.C.. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington D.C.
Malignant Solid Neoplasm (5)Alzheimer Disease (4)Prostate Cancer (3)Solid Tumor (3)Ewing Sarcoma (3)Hepatocellular Carcinoma (3)Myeloproliferative Neoplasm (2)Acute Treatment of Migraine (2)Asthma in Children (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Lymphoblastic Leukemia (2)Acute Myeloid Leukemia (2)
NCT07003984 Phase 3
Recruiting
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Condition
Chikungunya Virus
Enrollment
720 pts
Location
United States, Philippines, Puerto Rico
Sponsor
Bavarian Nordic
NCT06385184 N/A
Recruiting
Social & QoL Behaviors in Parkinson's Disease
Condition
Parkinson Disease
Enrollment
500 pts
Location
United States
Sponsor
Gregory Wallace
NCT06166433 N/A
Recruiting
Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia
Condition
Second Hand Tobacco Smoke
Enrollment
550 pts
Location
United States
Sponsor
George Washington University
NCT06544499 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participan...
Condition
Primary Immune Thrombocytopenia (ITP)
Enrollment
69 pts
Location
United States, Austria, Bulgaria
Sponsor
argenx
NCT06808984 Phase 2
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the ...
Condition
Agitation
Enrollment
120 pts
Location
United States
Sponsor
Celgene
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06995729 Phase 1
Recruiting
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Chi...
Condition
Acute Treatment of Migraine
Enrollment
16 pts
Location
United States
Sponsor
Pfizer
NCT05332067 Phase 2
Recruiting
Omalizumab Before Onset of Exacerbations
Condition
Asthma in Children
Enrollment
300 pts
Location
United States
Sponsor
Children's National Research I
NCT06597019 Phase 3
Recruiting
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygou...
Condition
Familial Hypercholesterolemia - Heterozygous
Enrollment
51 pts
Location
United States, Argentina, Austria
Sponsor
Novartis Pharmaceuticals
NCT07431853 Phase 2
Recruiting
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Condition
Healthy Adults
Enrollment
770 pts
Location
United States
Sponsor
Pfizer
NCT06792695 Phase 2
Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Color...
Condition
Metastatic Colorectal Cancer
Enrollment
120 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT05040178 N/A
Recruiting
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults an...
Condition
Hyperammonemia
Enrollment
20 pts
Location
United States
Sponsor
RECORDATI GROUP
NCT05919680 Phase 2
Recruiting
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease...
Condition
Intestinal Failure Associated Liver Disease
Enrollment
36 pts
Location
United States
Sponsor
NorthSea Therapeutics B.V.
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT01206920 N/A
Recruiting
The DC Cohort Longitudinal HIV Status Neutral Study
Condition
HIV
Enrollment
19,000 pts
Location
United States
Sponsor
George Washington University
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT06026969 N/A
Recruiting
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease ...
Condition
Lyme Disease
Enrollment
40 pts
Location
United States
Sponsor
Children's National Research I
NCT06532656 Phase 2, Phase 3
Recruiting
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
Condition
HIV-1-infection
Enrollment
75 pts
Location
United States, Argentina, Italy
Sponsor
Gilead Sciences
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
NCT04870944 Phase 1, Phase 2
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS ...
Condition
Diffuse Midline Glioma, H3 K27-Altered
Enrollment
63 pts
Location
United States, Australia
Sponsor
Children's Oncology Group
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT04929028 Phase 2
Recruiting
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Condition
AIDS-Related Anal Carcinoma
Enrollment
40 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
Page 1 of 6 — 139 trials total